JNLClass II
Immunochemical, Thyroglobulin Autoantibody
21 CFR 866.5870 / Immunology
JNL is the FDA product code for Immunochemical, Thyroglobulin Autoantibody, a class II device type, regulated under 21 CFR 866.5870. As of , FDA records hold 22 510(k) clearances under this code, the most recent dated , and 4 recalls.
Classification record
- Product code
- JNL
- Device name
- Immunochemical, Thyroglobulin Autoantibody
- Regulation
- 21 CFR 866.5870
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 22
- Ingested recalls
- 4
Clearances, product code JNL
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1990 | 1 |
| 1991 | 1 |
| 1992 | 3 |
| 1993 | 1 |
| 1994 | 2 |
| 1995 | 6 |
| 1996 | 2 |
| 1997 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code JNL| Applicant | Clearances |
|---|---|
| Siemens Healthcare Diagnostics Inc. | 4 |
| Immunoprobe, Inc. | 4 |
| Cogent Diagnotics, Ltd. | 3 |
| General Biometrics, Inc. | 2 |
| Hycor Biomedical | 2 |
| bioMerieux, Inc. | 2 |
| Biomerica | 1 |
| Elias U.S.A., Inc. | 1 |
| Monobind, Inc. | 1 |
| Nichols Institute | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
